S 33516
Latest Information Update: 09 Aug 2002
At a glance
- Originator Servier
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 29 Nov 1999 New profile
- 29 Nov 1999 Preclinical development for Osteoarthritis in France (PO)
- 29 Nov 1999 Preclinical development for Rheumatoid arthritis in France (PO)